-
LIPO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Lipella Pharmaceuticals (LIPO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.35 mm | 1.35 mm | 1.35 mm | 1.35 mm | 1.35 mm | 1.35 mm |
Cash burn (monthly) | (no burn) | 88.01 k | 486.47 k | 363.24 k | 217.70 k | 307.34 k |
Cash used (since last report) | n/a | 445.72 k | 2.46 mm | 1.84 mm | 1.10 mm | 1.56 mm |
Cash remaining | n/a | 908.02 k | -1.11 mm | -485.85 k | 251.21 k | -202.75 k |
Runway (months of cash) | n/a | 10.3 | -2.3 | -1.3 | 1.2 | -0.7 |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 2 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 28.06 mm |
Total shares | 77.05 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 34.52 k | $16.29 mm |
Geode Capital Management | 24.92 k | $11.76 mm |
HRT Financial | 17.62 k | $8.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jan 25 | Jonathan H Kaufman | Common Stock Purchase Warrants Common Stock | Other | Dispose J | Yes | No | 1 | 11,795 | 11.80 k | 0 |
15 Jan 25 | Jonathan H Kaufman | Common Stock Purchase Warrants Common Stock | Other | Dispose J | Yes | No | 1 | 85,421 | 85.42 k | 0 |
15 Jan 25 | Jonathan H Kaufman | Series C Voting Convertible Preferred Stock Common Stock | Other | Dispose J | Yes | No | 1 | 303,041 | 303.04 k | 0 |
31 Dec 24 | Jonathan H Kaufman | Common Stock Purchase Warrants Common Stock | Other | Acquire J | Yes | No | 1 | 11,795 | 11.80 k | 11,795 |
31 Dec 24 | Jonathan H Kaufman | Series C Voting Convertible Preferred Stock Common Stock | Other | Acquire J | Yes | No | 1 | 42,933 | 42.93 k | 303,041 |
23 Dec 24 | Jonathan H Kaufman | Common Stock Purchase Warrants Common Stock | Other | Acquire J | Yes | No | 1 | 85,421 | 85.42 k | 85,421 |
23 Dec 24 | Jonathan H Kaufman | Series C Voting Convertible Preferred Stock Common Stock | Other | Acquire J | Yes | No | 1 | 260,108 | 260.11 k | 260,108 |
14 May 24 | Jonathan H Kaufman | Common Stock | Buy | Acquire P | No | No | 0.759 | 10,000 | 7.59 k | 898,849 |
15 Mar 24 | Lori Birder | Stock Options Common Stock | Grant | Acquire A | No | No | 0.77 | 25,000 | 19.25 k | 25,000 |